Gaucher’s
Shire revenue dips after generic Adderall hit
April 30, 2010Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire
Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva. This …
Genzyme fined $175m for manufacturing problems
April 22, 2010Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance
The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …
Shire launches Vpriv to capitalise on Genzyme woes
March 2, 2010Sales and Marketing Cerezyme, Gaucher's, Shire
Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …
Shire readies Gaucher drug Vpriv
February 23, 2010Manufacturing and Production Cerezyme, Gaucher's, Shire, Vpriv
Shire Pharmaceuticals says it has already manufactured enough of its Vpriv to treat around 400 Gaucher disease patients and could …
Shire goes for early approval in Gaucher disease
September 1, 2009Research and Development, Sales and Marketing Gaucher's, Shire
Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …
